期刊文献+

体外循环聚氯乙烯管路地塞米松涂层的性能 被引量:3

Performance of dexamethasone coated polyvinyl chloride pipeline in the extracorporeal circulation
暂未订购
导出
摘要 背景:将地塞米松以某种涂层方式固定到体外循环管道表面,既可持续地起到抗炎作用,又不至于由于血药浓度过大而产生不良反应,最大限度地发挥地塞米松的抗炎作用。目的:研制新型抗凝血活性的地塞米松磷酸钠涂层管路,评价涂层管道稳定性、抗凝活性及抗血小板等性能。方法:用浓硫酸、聚乙烯亚胺依次预处理聚氯乙烯体外循环管路表面。分别通过预混、离子键两种方式制备地塞米松磷酸钠涂层聚氯乙烯体外循环管道,对涂层管道进行涂层物定量分析,以未涂层的聚氯乙烯体外循环管路为空白对照,评价3组抗凝血、抗血小板、抗蛋白黏附等性能及涂层聚氯乙烯体外循环管道的体外释放特性。结果与结论:预混及离子键制备的地塞米松磷酸钠涂层聚氯乙烯管道表面固定地塞米松磷酸钠的最大固定量分别为(2.06±0.68),(3.33±0.75)μg/cm2。预混制备的地塞米松磷酸钠涂层聚氯乙烯管道抗凝血、抗血小板及蛋白黏附效果优于离子键制备的地塞米松磷酸钠涂层聚氯乙烯管道和空白对照组(P<0.05),且体外释放效果优于离子键制备的地塞米松磷酸钠涂层聚氯乙烯管道。表明通过预混方式制备的地塞米松磷酸钠涂层缓释及抗凝性能良好,有抗血小板黏附及血栓形成的功能,能满足体外循环中短期转流的要求。 BACKGROUND: Dexamethasone as coating is fixed to the surface of cardiopulmonary bypass pipe, which can maintain sustainable anti-inflammatory effects and avoid adverse reactions due to excessive blood concentration, thereby maximizing the anti-inflammatory action of dexamethasone. OBJECTIVE: To develop a new coating method of dexamethasone sodium phosphate, which has anticoagulation activity, and to evaluate the performance of the coated pipeline, including the stability, anticoagulant and antiplatelet activity. METHODS: The surface of polyvinyl chloride pipelines in the extracorporeal circulation was successively pretreated with strong sulfuric acid and polyethylene imines. Dexamethasone sodium phosphate coated pipelines were made through two methods: ionic blond and premix. Then, a quantitative analysis was performed to evaluate anticoagulation, antiplatelet, resistance of protein adhesion and antithrombosis function. Non-coated polyvinyl chloride pipeline served as control group. RESULTS AND CONCLUSION: The biggest drug loadings were (2.06 ±0.68) and (3.33±0.75) μg/cm2 for dexamethasone sodium phosphate coated polyvinyl chloride pipelines prepared by premix and ionic blond, respectively. In the anticoagulation, antiplatelet, and resistance of protein adhesion experiment, dexamethasone sodium phosphate coated polyvinyl chloride pipelines prepared by premix were superior to those prepared by ionic blond and control group (P 〈 0.05). Release in vitro experiment showed that dexamethasone sodium phosphate coated polyvinyl chloride pipelines prepared by premix were also superior to those prepared by ionic blond. The findings indicate that the dexamethasone sodium phosphate coating prepared by premix shows better release and anticoagulation performance, as wel as forms antiplatelet adhesion and antithrombosis function, to meet the short-term extracorporeal circulation requirements.
出处 《中国组织工程研究》 CAS CSCD 2013年第12期2177-2184,共8页 Chinese Journal of Tissue Engineering Research
基金 天津市科委支撑项目(11ZCGYSY02000) 课题名称:人工心肺支持系统肝素涂层管路研制后实验及临床应用研究~~
关键词 生物材料 生物材料与药物控释 地塞米松磷酸钠 海藻酸钠 聚氯乙烯 缓释 涂层 生物相容性 其他基金 生物材料图片文章 biomaterials biomaterials and controlled drug release dexamethasone sodium phosphate sodiumalginate polyvinyl chloride slow-release coating biocompatibility other grants-supported paper biomaterialphotographs-containing paper
  • 相关文献

参考文献12

  • 1范颖,姚静,周建平.细胞核靶向聚乙烯亚胺-地塞米松偶联物的制备及作为基因载体的应用[J].高等学校化学学报,2011,32(12):2916-2922. 被引量:5
  • 2陈勇鹏,王贵学,陈琰,晋献春,侯延斌,罗来龙,孙大贵.地塞米松血管内支架的涂层制备及体外缓释实验研究[J].第三军医大学学报,2008,30(10):935-937. 被引量:7
  • 3Smith PK,Krohn RI,Hermanson GT,et al.Measurement of protein using bicinchoninic acid[].Analytical Biochemistry.1985
  • 4Gardner R A.An examination of the fluid mechanics and thrombus formation time parameters in a chandler rotating loop system[].Journal of Laboratory and Clinical Medicine.1974
  • 5Beato M,Herrlich P,Schutz G.Steroid hormone receptors: many actors in search of a plot[].Cell.1995
  • 6Goulding NJ.The molecular complexity of glucocorticoid actionsin inflammation-a four-ring circus[].Current Opinion in Pharmacology.2004
  • 7Replogle RL,Gazzaniga AB,Gross RE.Use of corticosteroids during cardiopulmonary bypass: possible lysosome stabilization[].Circulation.1996
  • 8Le-Tien C,Millette M,Lacroix M,et al.Modified alginate ma-trices for the immobilization of bioactive agents[].Biotechnolo-gy and Applied Biochemistry.2004
  • 9Guo QK,Lu ZQ,Wang JY,Li T.In vivo evaluation of a novel dexamethasone-heparin-double-coated stent for inhibition of artery restenosis and thrombosis[].Journal of Materials Science-Materials in Medicine.2011
  • 10Ribichini F,Tomai F,Paloscia L,et al.Steroid-Eluting Stents in Patients with A-cute Coronary Syndromes.The DESIRE:Dexamethasone Eluting Stent Italian Registry[].Heart.2007

二级参考文献26

  • 1王建波,杨建勇,陈伟,庄文权,张珑涓,李家平.地塞米松对血管内支架介入术后再狭窄作用的实验研究[J].介入放射学杂志,2007,16(3):194-197. 被引量:6
  • 2Yannaki E. , Emery D. W. , Stamatoyannopoulos G.. Expert Rev. Mol. Med. [J], 2010, 12:e31.
  • 3Hashemi M. , Parhiz B. H. , Hatefi A. , Ramezani M.. Cancer Gene Ther. [J], 2011, 18(1 ) : 12-19.
  • 4Zhang C. , Gao S. , Jiang W. , Lin S. , Du F. , Li Z. , Huang W.. Biomaterials[ J], 2010, 31(23) : 6075-6086.
  • 5Yao J., Fan Y., Du R., Zhou J., Lu Y., Wang W., Ren J., Sun X.. Biomaterials[ J], 2010, 31(35) : 9357-9365.
  • 6Huh M. S., Lee S. Y., Park S., Lee S., Chung H., Lee S., Choi Y,, Oh Y. K., Park J. H., Jeong S. Y., Choi K., Kim K., Kwon I. C.. J. Control Release[J] , 2010, 144(2) : 134-143.
  • 7Glover D. J. , Leyton D. L. , Moseley G. W. , Jans D. A.. J. Gene Med. [J], 2010, 12(1) : 77-85.
  • 8Cohen R. N. , van der Aa M. A. E. M. , Macaraeg N. , Lee A. P. , Szoka F. C. Jr.. J. Control Reldase[J], 2009, 135(2) : 166- 174.
  • 9Choi J. S., Ko K. S., Park J. S., Kim Y. H., Kim S. W., Lee M.. Int. J. Pharm. [J], 2006, 320(1/2) : 171-178.
  • 10Kim H. , Bae Y. M. , Kim H. A., Hyun H. , Yu G. S. , Choi. J. S. , Lee M.. J. Cell Bioehem. [J], 2010, 110(3) : 743-751.

共引文献9

同被引文献50

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部